Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

3 years ago

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative…

ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021

3 years ago

ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021 Conference call and webcast on Tuesday,…

Wesana Provides Updates on Build-out of Third Clinic

3 years ago

Naperville clinic to open Spring 2022CHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc.  (“Wesana” or…

Roivant to Present at Targeted Protein Degradation Conference

3 years ago

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today…

 Inventiva announces filing of its 2021 Universal Registration Document and 2021 Annual Report on Form 20-F

3 years ago

Daix (France), Long Island City (New York, United States), March 11, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…

Sienna Senior Living Enters Into an Agreement to Purchase a Retirement Residence in Saskatchewan

3 years ago

MARKHAM, Ontario, March 11, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX:SIA) announced today that…

Cellectis to Participate in Two Upcoming Investor Conferences in March

3 years ago

NEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology…

AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

3 years ago

PHILADELPHIA, March 11, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a…

Biogen to Present New Research at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 2022)

3 years ago

CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer’s disease research,…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022

3 years ago

Monthly information regarding the total number of voting rights and total number of shares of the Company as of February…